Compare Stocks: XAGE, ABP, PPBT, and SCNI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABP Abpro	$0.52	$0.52	$0.52 ▼ $29.97	$1.42M	N/A	5.06 million shs	N/A
PPBT Purple Biotech	$1.50 +4.9%	$1.76	$1.16 ▼ $24.00	$1.33M	0.67	27,296 shs	973,769 shs
SCNI Scinai Immunotherapeutics	$0.25 +2.4%	$0.29	$0.21 ▼ $1.97	$1.27M	2.08	860,274 shs	138,248 shs
XAGE Longevity Health	$0.28 -11.9%	$0.26	$0.21 ▼ $2.85	$499K	0.4	2,557 shs	598 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABP Abpro	0.00%	0.00%	0.00%	0.00%	-92.93%
PPBT Purple Biotech	+4.90%	+2.04%	-3.54%	-61.04%	-92.96%
SCNI Scinai Immunotherapeutics	+2.45%	-7.95%	+0.24%	-52.85%	-83.47%
XAGE Longevity Health	-11.95%	+24.28%	+24.44%	-18.06%	-89.63%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABP Abpro	$0.52	$0.52	$0.52 ▼ $29.97	$1.42M	N/A	5.06 million shs	N/A
PPBT Purple Biotech	$1.50 +4.9%	$1.76	$1.16 ▼ $24.00	$1.33M	0.67	27,296 shs	973,769 shs
SCNI Scinai Immunotherapeutics	$0.25 +2.4%	$0.29	$0.21 ▼ $1.97	$1.27M	2.08	860,274 shs	138,248 shs
XAGE Longevity Health	$0.28 -11.9%	$0.26	$0.21 ▼ $2.85	$499K	0.4	2,557 shs	598 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABP Abpro	0.00%	0.00%	0.00%	0.00%	-92.93%
PPBT Purple Biotech	+4.90%	+2.04%	-3.54%	-61.04%	-92.96%
SCNI Scinai Immunotherapeutics	+2.45%	-7.95%	+0.24%	-52.85%	-83.47%
XAGE Longevity Health	-11.95%	+24.28%	+24.44%	-18.06%	-89.63%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABP Abpro	1.50	Reduce	N/A	N/A
PPBT Purple Biotech	2.00	Hold	$30.00	1,900.00% Upside
SCNI Scinai Immunotherapeutics	1.00	Sell	N/A	N/A
XAGE Longevity Health	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest XAGE, ABP, PPBT, and SCNI Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/3/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
7/17/2026	SCNI Scinai Immunotherapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/16/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
6/26/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
6/11/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
5/22/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)

(Data available from 8/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABP Abpro	N/A	N/A	N/A	N/A	($8.83) per share	N/A
PPBT Purple Biotech	N/A	N/A	N/A	N/A	$10.39 per share	N/A
SCNI Scinai Immunotherapeutics	$1.31M	0.99	N/A	N/A	$0.78 per share	0.32
XAGE Longevity Health	$1.05M	0.47	N/A	N/A	($6.77) per share	-0.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABP Abpro	-$7.23M	-$4.23	N/A	N/A	N/A	N/A	N/A	-344.76%	N/A
PPBT Purple Biotech	-$26.39M	-$23.25	N/A	N/A	N/A	N/A	-136.79%	-100.38%	N/A
SCNI Scinai Immunotherapeutics	-$8.31M	-$1.06	N/A	N/A	N/A	N/A	N/A	N/A	8/20/2026 (Estimated)
XAGE Longevity Health	-$10.37M	-$4.29	N/A	N/A	N/A	-682.67%	N/A	-261.90%	N/A

Latest XAGE, ABP, PPBT, and SCNI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/16/2026	Q1 2026	PPBT Purple Biotech	-$0.38	-$0.09	+$0.29	$0.09	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABP Abpro	N/A	N/A	N/A	N/A	N/A
PPBT Purple Biotech	N/A	N/A	N/A	N/A	N/A
SCNI Scinai Immunotherapeutics	N/A	N/A	N/A	N/A	N/A
XAGE Longevity Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABP Abpro	N/A	0.07	0.07
PPBT Purple Biotech	N/A	1.48	1.48
SCNI Scinai Immunotherapeutics	0.05	1.35	1.35
XAGE Longevity Health	N/A	0.47	0.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABP Abpro	23.30%
PPBT Purple Biotech	9.64%
SCNI Scinai Immunotherapeutics	58.41%
XAGE Longevity Health	24.22%

Insider Ownership

Company	Insider Ownership
ABP Abpro	13.70%
PPBT Purple Biotech	2.98%
SCNI Scinai Immunotherapeutics	6.03%
XAGE Longevity Health	29.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABP Abpro	15	2.72 million	2.34 million	N/A
PPBT Purple Biotech	20	930,000	901,000	Optionable
SCNI Scinai Immunotherapeutics	20	5.17 million	4.86 million	Not Optionable
XAGE Longevity Health	14	1.78 million	1.27 million	N/A

XAGE, ABP, PPBT, and SCNI Headlines

Recent News About These Companies

Longevity Health Announces Routine Board Member Resignation

June 4, 2026 | tipranks.com

Head to Head Contrast: Longevity Health (NASDAQ:XAGE) & Biosig Technologies (NASDAQ:STEX)

March 27, 2026 | defenseworld.netD

Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth

March 17, 2026 | globenewswire.com

Longevity Health Holdings Ends Merger with True Health

December 12, 2025 | tipranks.com

Why Longevity Health Stock Is Skyrocketing Today

July 15, 2025 | benzinga.com

Why Longevity Health Stock Is Skyrocketing Today

July 15, 2025 | benzinga.com

Why did XAGE Stock Surge in Today’s Premarket Trading?

July 15, 2025 | tokenist.comT

Longevity Health Holdings, Inc.: Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction

July 15, 2025 | finanznachrichten.de

Longevity Health Holdings to Merge With True Health

July 15, 2025 | marketwatch.com

Longevity Health stock soars after merger with THPlasma in all-stock deal

July 15, 2025 | investing.com

Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction

July 14, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAGE, ABP, PPBT, and SCNI Company Descriptions

Abpro NASDAQ:ABP

$0.52 0.00 (0.00%)

As of 08/7/2026

Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

Purple Biotech NASDAQ:PPBT

$1.50 +0.07 (+4.90%)

Closing price 08/10/2026 04:00 PM Eastern

Extended Trading

$1.46 -0.04 (-2.73%)

As of 07:32 AM Eastern

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.

Scinai Immunotherapeutics NASDAQ:SCNI

$0.25 +0.01 (+2.45%)

Closing price 08/10/2026 04:00 PM Eastern

Extended Trading

$0.24 -0.02 (-6.09%)

As of 07:06 AM Eastern

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Longevity Health NASDAQ:XAGE

$0.28 -0.04 (-11.95%)

As of 08/10/2026 12:35 PM Eastern

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest XAGE, ABP, PPBT, and SCNI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest XAGE, ABP, PPBT, and SCNI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

XAGE, ABP, PPBT, and SCNI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAGE, ABP, PPBT, and SCNI Company Descriptions

Abpro NASDAQ:ABP

Purple Biotech NASDAQ:PPBT

Scinai Immunotherapeutics NASDAQ:SCNI

Longevity Health NASDAQ:XAGE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest XAGE, ABP, PPBT, and SCNI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest XAGE, ABP, PPBT, and SCNI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

XAGE, ABP, PPBT, and SCNI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAGE, ABP, PPBT, and SCNI Company Descriptions

Abpro NASDAQ:ABP

Purple Biotech NASDAQ:PPBT

Scinai Immunotherapeutics NASDAQ:SCNI

Longevity Health NASDAQ:XAGE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools